Literature DB >> 6837304

Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects.

A Arvidsson, G Alván, B Strandvik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6837304     DOI： 10.1111/j.1651-2227.1983.tb09715.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN： 0001-656X


× No keyword cloud information.
  18 in total

Review 1.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 2.  Drug disposition in cystic fibrosis.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

3.  Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.

Authors:  A Hedman; G Alván; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

4.  Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.

Authors:  A Hedman; Y Adan-Abdi; G Alvan; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

Review 5.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 6.  High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.

Authors:  F Sörgel; U Stephan; H G Wiesemann; B Gottschalk; C Stehr; M Rey; H B Böwing; H C Dominick; M Geldmacher von Mallinckrodt
Journal:  Infection       Date:  1987       Impact factor: 3.553

7.  Pharmacokinetics of cefepime in cystic fibrosis patients.

Authors:  C E Huls; R A Prince; D K Seilheimer; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

Review 8.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 9.  Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.

Authors:  D J Touw; A A Vinks; J W Mouton; A M Horrevorts
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

10.  Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.

Authors:  M D Reed; R C Stern; T S Yamashita; I Ackers; C M Myers; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.